Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction [NA]

View source ↗

Summary

This clinical trial update reports that the COMPASSION S3 study evaluating the SAPIEN 3 transcatheter heart valve for pulmonary valve dysfunction is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAPIEN 3 Transcatheter Heart Valve (transcatheter heart valve)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Complex Congenital Heart Defect, Dysfunctional RVOT Conduit | NA | Status: RECRUITING